Skip to main content

Engineers Gate Manager LP

SEC CIK
0001620220
Latest filing
Aug 14, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
33,469
Value
$10.1M
% of portfolio
0.1%
Quarters held
19
Since Q1 2021
Holdings of ALNY by Engineers Gate Manager LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,469$10.1M0.1%+967+3.0%AddedHolders
Q1 202632,502$10.8M0.1%+12,303+60.9%AddedHolders
Q4 202520,199$8.03M0.1%−23,650−53.9%ReducedHolders
Q3 202543,849$20.0M0.2%+11,219+34.4%AddedHolders
Q2 202532,630$10.6M0.1%+7,238+28.5%AddedHolders
Q1 202525,392$6.86M0.1%−8,505−25.1%ReducedHolders
Q4 202433,897$7.98M0.1%+22,034+185.7%AddedHolders
Q3 202411,863$3.26M0.1%+4,789+67.7%AddedHolders
Q2 20247,074$1.72M<0.1%−17,649−71.4%ReducedHolders
Q1 202424,723$3.69M0.1%+7,292+41.8%AddedHolders
Q4 202317,431$3.34M0.1%+17,431NewHolders
Q3 20230$00.0%−5,286−100.0%Sold outHolders
Q2 20235,286$1.00M<0.1%−909−14.7%ReducedHolders
Q1 20236,195$1.24M0.1%+6,195NewHolders
Q4 20220$00.0%−1,957−100.0%Sold outHolders
Q3 20221,957$392.0K<0.1%−3,467−63.9%ReducedHolders
Q2 20225,424$791.0K<0.1%+5,424NewHolders
Q1 20220$00.0%−1,990−100.0%Sold outHolders
Q4 20211,990$337.0K<0.1%+856+75.5%AddedHolders
Q3 20211,134$214.0K<0.1%−14,830−92.9%ReducedHolders
Q2 202115,964$2.71M0.2%+13,054+448.6%AddedHolders
Q1 20212,910$411.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.